Kristoffer Berg-Hansen

Department of Cardiology, Aarhus University Hospital

Affiliated withAarhus University Hospital Aarhus University Horsens Regional Hospital

Research Area

Biography

Kristoffer Berg-Hansen has not added Biography.
If you are Kristoffer Berg-Hansen and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Myocardial efficiency in patients with different aetiologies and stages of heart failure. European heart journal. Cardiovascular Imaging\| PubMed ID: 34751738	2022
Prolonged Cardiogenic Shock Due to Hydrogen Sulfide Intoxication Requiring Long-Term Venoarterial Extracorporeal Membrane Support. JACC. Case reports\| PubMed ID: 36388715	2022
Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension. Journal of the American Heart Association\| PubMed ID: 37183871	2023
The haemodynamic effects of phenylephrine after cardiac surgery. Acta anaesthesiologica Scandinavica\| PubMed ID: 37186094	2023
Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3-Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects. Journal of the American Heart Association\| PubMed ID: 37301762	2023
Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock: A Randomized, Controlled, Double-Blind Trial. JACC. Heart failure\| PubMed ID: 37452805	2023
Myocardial work across different etiologies of right ventricular dysfunction and healthy controls. The international journal of cardiovascular imaging\| PubMed ID: 38305942	2024
Effects of exogenous lactate on lipid, protein, and glucose metabolism-a randomized crossover trial in healthy males. American journal of physiology. Endocrinology and metabolism\| PubMed ID: 38324259	2024
Lactate infusion elevates cardiac output through increased heart rate and decreased vascular resistance: a randomised, blinded, crossover trial in a healthy porcine model. Journal of translational medicine\| PubMed ID: 38493167	2024
Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial. Circulation\| PubMed ID: 38533643	2024
Enantiomer-Specific Cardiovascular Effects of the Ketone Body 3-Hydroxybutyrate. Journal of the American Heart Association\| PubMed ID: 38563382	2024
Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Circulation\| PubMed ID: 39162035	2024
Cardiovascular Effects of Increasing Positive End-Expiratory Pressure in A Model of Left Ventricular Cardiogenic Shock in Female Pigs. Anesthesiology\| PubMed ID: 39186681	2024
Global longitudinal strain is a predictor of mortality in patients with cardiogenic shock. European heart journal. Cardiovascular Imaging\| PubMed ID: 39657586	2025
Neurohormonal and Renal Effects of 14-Day Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction. Circulation. Heart failure\| PubMed ID: 39717923	2025
Cardiovascular and Metabolic Effects of Modulating Circulating Ketone Bodies With 1,3-Butanediol in Patients With Heart Failure With Reduced Ejection Fraction. Journal of the American Heart Association\| PubMed ID: 39719429	2025
Cardiovascular effects of lactate in healthy adults. Critical care (London, England)\| PubMed ID: 39825426	2025
Butyrate increases cardiac output and causes vasorelaxation in a healthy porcine model. Life sciences\| PubMed ID: 39828226	2025
Lactate infusion improves cardiac function in a porcine model of ischemic cardiogenic shock. Critical care (London, England)\| PubMed ID: 40083003	2025
Metabolic profiles associate with mortality and neurological outcomes in out-of-hospital cardiac arrest patients. Resuscitation\| PubMed ID: 40090610	2025
The Venous-to-Arterial Carbon Dioxide Difference is an Indicator of Cardiac Index in Cardiogenic Shock Complicating Myocardial Infarction-A Porcine Study. Heart, lung & circulation\| PubMed ID: 40140267	2025
The ketone body 3-hydroxybutyrate increases cardiac output and cardiac contractility in a porcine model of cardiogenic shock: a randomized, blinded, crossover trial. Basic research in cardiology\| PubMed ID: 40220139	2025
Cardiovascular effects of lactate in healthy adults: D-lactate, the forgotten enantiomer-authors' reply. Critical care (London, England)\| PubMed ID: 40270027	2025
The Cardiac and Hemodynamic Effects of Ketone Bodies Are Abnormal in Patients With Type 1 Diabetes: A Randomized Controlled Trial. Diabetes\| PubMed ID: 40526464	2025
The Immediate Cardiovascular and Mitochondrial Response in Ischemic Cardiogenic Shock. Journal of cardiovascular translational research\| PubMed ID: 40555857	2025
Should Exogenous Ketone Body Supplementation Be Considered in Patients Hospitalized for Acute Heart Failure? Rationale and Design of the KETO-AHF Trial. Journal of cardiac failure\| PubMed ID: 40789530	2025
Three-week Alternate-day Fasting Improves Myocardial Flow Reserve and Reduces Oxygen Use in Overweight Individuals. The Journal of clinical endocrinology and metabolism\| PubMed ID: 40890042	2026
Cardiovascular effects of hypertonic lactate solutions: acid-base or metabolic cause, or both? Authors' reply. Critical care (London, England)\| PubMed ID: 41121333	2025
Gap PCO in the operating room: Lessons from cardiopulmonary bypass. Anaesthesia, critical care & pain medicine\| PubMed ID: 41308978	2026
Ketone bodies for hemodynamic support in acute pulmonary embolism: a randomized, blinded, controlled animal study. Intensive care medicine experimental\| PubMed ID: 41420069	2025
Serial measurements of myocardial efficiency in patients with aortic valve stenosis: pathophysiological mechanisms and prognostic implications. American journal of physiology. Heart and circulatory physiology\| PubMed ID: 41661147	2026
Not racemic after all: stereochemical composition of a commercially available sodium lactate solution. Critical care (London, England)\| PubMed ID: 41928298	2026